Skip to content

Pharming Group N.V.

LEI 724500DCJ9MPG74JEH91Netherlandsfmd_14ZY0ZRCC1HSNJ6RQ1TTYGN3RATemplate: Standard

This company files annual reports on an EU or UK regulated market, not with the SEC. Statements come from its ESEF annual report in USD and are not converted. Ownership, prices, dividends and events are built from SEC and US market data and are not available for it.

Coverage: Jan 01, 2020 to Dec 31, 2025, 6 periods

Income Statement · Annual · Millions · USD
Line itemFY2020FY2021FY2022FY2023FY2024FY2025
Total revenues212199206245297376
Cost of revenue242118253546
Gross profit189178188220262331
Research and development3970536983100
Selling, general and administrative7696132180189211
Operating income761418(5)(9)26
Interest expense336591018
Income before taxes442315(12)(8)13
Income tax expense671(1)310
Net income from continuing operations381614(11)(12)3
Net income381614(11)(12)3